Holdings (as at 2026-05-13)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Organon & Co. 3.81%
Humana Inc. 3.76%
Elevance Health Inc. 2.92%
DaVita Inc. 2.76%
Exelixis, Inc. 2.56%
Molina Healthcare, Inc. 2.46%
Solventum Corporation 2.44%
The Cigna Group 2.41%
Biogen Inc. 2.39%
Incyte Corporation 2.25%
Universal Health Services, Inc. (Class B) 2.04%
Regeneron Pharmaceuticals, Inc. 2.00%
Zimmer Biomet Holdings, Inc. 1.96%
HCA Healthcare, Inc. 1.93%
Chemed Corporation 1.92%
Encompass Health Corporation 1.90%
Cardinal Health, Inc. 1.89%
Globus Medical, Inc. (Class A) 1.88%
Bio-Rad Laboratories, Inc. (Class A) 1.87%
Tenet Healthcare Corporation 1.78%
Ionis Pharmaceuticals, Inc. 1.77%
Masimo Corporation 1.72%
United Therapeutics Corporation 1.68%
Penumbra, Inc. 1.68%
Amgen Inc. 1.64%
Merck & Co., Inc. 1.61%
Pfizer Inc. 1.58%
Becton, Dickinson and Company 1.57%
Illumina, Inc. 1.51%
QIAGEN N.V. 1.40%
Revvity, Inc. 1.39%
UnitedHealth Group Incorporated 1.27%
Quest Diagnostics Incorporated 1.25%
Natera, Inc. 1.25%
Gilead Sciences, Inc. 1.23%
Insmed Incorporated 1.23%
Steris Plc 1.22%
Labcorp Holdings Inc. 1.22%
Henry Schein, Inc. 1.21%
Bristol-Myers Squibb Company 1.19%
ResMed Inc. 1.16%
Medtronic Plc 1.13%
GE HealthCare Technologies Inc. 1.12%
Sarepta Therapeutics, Inc. 1.11%
Certara, Inc. 1.08%
The Cooper Companies, Inc. 1.07%
Neurocrine Biosciences, Inc. 1.05%
Waters Corporation 0.96%
Eli Lilly and Company 0.94%
Halozyme Therapeutics, Inc. 0.93%
IQVIA Holdings Inc. 0.86%
Agilent Technologies, Inc. 0.85%
Johnson & Johnson 0.81%
BioMarin Pharmaceutical Inc. 0.81%
Align Technology, Inc. 0.81%
Thermo Fisher Scientific Inc. 0.78%
Medpace Holdings, Inc. 0.76%
Medline Inc. (Class A) 0.74%
Abbott Laboratories 0.70%
Zoetis Inc. 0.54%
West Pharmaceutical Services, Inc. 0.48%
Royalty Pharma Plc (Class A) 0.45%
Sotera Health Company 0.43%
Vertex Pharmaceuticals Incorporated 0.41%
Edwards Lifesciences Corporation 0.41%
Viking Therapeutics, Inc. 0.39%
Intuitive Surgical, Inc. 0.38%
AbbVie Inc. 0.38%
Envista Holdings Corporation 0.38%
Stryker Corporation 0.37%
IDEXX Laboratories, Inc. 0.37%
DexCom, Inc. 0.37%
Veeva Systems Inc. (Class A) 0.36%
Danaher Corporation 0.35%
Alnylam Pharmaceuticals, Inc. 0.35%
Boston Scientific Corporation 0.34%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.